Bengaluru-based healthtech startup Healthify has secured an additional $20 million in funding, bringing its pre-Series D round to $45 million. The investment was led by existing investors Khosla Ventures and LeapFrog Investments, with participation from new investor Claypond Capital, the family office of healthcare billionaire Dr. Ranjan Pai.
The fresh capital will primarily fuel Healthify’s expansion into the US market and enhance its AI-driven nutrition and fitness coaching capabilities. The company, which combines artificial intelligence with human expertise to deliver personalized health solutions, has already conducted successful alpha tests in the US and plans to launch its beta app before the end of the year.
Founded in 2012 by Tushar Vashisht, Sachin Shenoy, and Mathew Cherian, Healthify has established a strong presence in India, serving over 40 million users across more than 300 cities through its platform that integrates software, wearable devices, and a team of over 600 coaches.
The startup has demonstrated impressive financial growth, with operating revenue rising 23.49% to INR 228.76 crore in FY23. More significantly, the company has achieved operational profitability in India and is on track to become EBITDA-positive by the end of FY25, showcasing a sustainable growth model.
Key Statistics:
- $125 million total equity funding raised to date
- 40+ million users across 300+ cities
- 600+ coaches on the platform
- 23.49% YoY revenue growth in FY23
- 10% reduction in net loss in FY23
- Part of $7 billion cumulative funding in Indian healthtech (2014-2024)
The expansion strategy involves offering more affordable solutions compared to existing US alternatives, leveraging its operations in India and robust AI capabilities. While the US market is expected to contribute a smaller percentage of revenue initially, the company anticipates generating hundreds of millions of dollars within five years.
This development has significant implications for India’s healthtech ecosystem, demonstrating that Indian startups can successfully scale globally while maintaining profitability in their home market. The company’s ability to blend AI technology with human expertise creates a replicable model for other Indian startups eyeing international markets.
Healthify’s success in securing substantial funding and its planned US expansion represents a significant milestone for Indian healthtech startups, showcasing their ability to compete in global markets while maintaining strong domestic operations. The company’s journey from a local health app to an international health tech platform illustrates the growing maturity and global ambitions of Indian startups.
